Some mesenchymal cells respond to stimulation by specific cations with increased cell proliferation. In the present study we have investigated whether the parathyroid/kidney/brain calcium-sensing receptor (PCaR) can mediate such mitogenic responses. We have expressed the recombinant rat PCaR in CCL39 hamster fibroblasts, which do not express a detectable endogenous cation sensor. The transfected cells responded to increased extracellular calcium concentrations ([Ca 2ϩ ] e ) with strong inositol phosphate (IP) formation, which was insensitive to pertussis toxin treatment of cells. We could not detect negative coupling of the receptor to adenylyl cyclase. 
3
H]thymidine incorporation experiments, increasing [Ca 2ϩ ] e from 1 to 4 mM was found to stimulate DNA synthesis weakly, but significantly. A strong potentiation of this response was observed in the presence of NPS R-568. [Ca 2ϩ ] e and NPS R-568 also synergized to increase cell numbers in cultures maintained in defined medium. In contrast to our expectations, no significant stimulation of IP formation or cell proliferation could be observed after stimulation of cells with the reported PCaR agonist gadolinium (Gd 3ϩ ) or with aluminum (Al 3ϩ ), which stimulates osteoblast proliferation. Gd 3ϩ actually inhibited IP formation stimulated by increased [Ca 2ϩ ] e as well as by thrombin and AlF 4 Ϫ , indicating toxicity. However, submaximal receptor stimulation by Gd 3ϩ was evident when intracellular calcium transients were measured in fluo-3-loaded cells. Our data show that PCaR can stimulate cell proliferation when expressed in an appropriate cellular context. However, it is unlikely that PCaR mediates the strong mitogenic effects elicited by the cations Gd 3ϩ and Al O CCASIONAL reports showing increased cell proliferation in response to cations appeared many years ago (1, 2) . The possible physiological role of such responses remained obscure. However, the observation that bone-forming osteoblasts respond to calcium and other cations (3, 4) provided a rational link to physiology; thus, this cationsensing mechanism might participate in regulation of the skeletal apposition of calcium circulating in plasma.
The circulating levels of calcium are mainly controlled by parathyroid cells that secrete the calcium-mobilizing PTH in response to a lowering of plasma calcium (5). Brown and co-workers recently demonstrated (6) that parathyroid calcium sensing is accomplished by a G protein-coupled receptor, PCaR. This receptor is activated by increased extracellular calcium concentrations ([Ca 2ϩ ] e ), but also responds to strontium, magnesium, and polycations such as neomycin B. In addition, transition metal ions such as Gd 3ϩ have been reported to act as very potent agonists at this receptor (5) (6) (7) (8) (9) . In fact, Gd 3ϩ was used to obtain the bovine PCaR complementary DNA (cDNA) through expression cloning (6) .
The present study was undertaken to investigate whether PCaR is able to trigger cell proliferation in mesenchymal cells. As a model system we chose CCL39 Chinese hamster lung fibroblasts, which are a well characterized system with respect to mitogenic signaling (10, 11) . It should be noted that these cells, like many other fibroblasts, are relatively refractory to mitogenic stimulation by G protein-coupled receptors, activating exclusively phosphoinositide turnover (10 -13) .
Experiments with bovine and human parathyroid cells have indicated that PCaR mediates the stimulation of phosphoinositide turnover and the inhibition of adenylyl cyclase, i.e. signals through both G q and G i proteins (5, 14) . In CCL39 cells transfected with the rat PCaR cDNA (15, 16), we could not detect negative modulation of adenylyl cyclase, but we measured a strong coupling to phosphoinositide turnover that was further potentiated by the calcimimetic drug NPS R-568, a compound acting like a positive allosteric modulator of PCaR function (17) . Increased [Ca 2ϩ ] e plus NPS R-568 strongly stimulated cell proliferation in a pertussis toxin (PTX)-insensitive manner. Cell culture media were purchased from Bioconcept (Basel, Switzerland). Recombinant basic fibroblast growth factor (FGF) was obtained from Bachem (Bubendorf, Switzerland), and human ␣-thrombin was purchased from Roche (Buchs, Switzerland). PTX, forskolin, fluo-3, and bovine insulin were purchased from Sigma (Buchs, Switzerland). Antibiotic G418 was obtained from Life Technologies (Basel, Switzerland). NPS R-568 was synthesized at Sandoz (Basel, Switzerland).
Materials and Methods Materials
were routinely grown in a 1:1 mixture of DMEM and Ham's F-12 (DMEM/F12) supplemented with 10% FCS and antibiotics (100 U/ml penicillin and 100 g/ml streptomycin). This medium mixture contains 1.05 mm Ca 2ϩ
. To obtain cells expressing the rat PCaR, CCl39 cells were transfected with the rat brain PCaR cDNA cloned into the pRK5 expression vector (15) using electroporation. Transfected cells were selected using antibiotic G418 (500 g/ml).
Inositol phosphate (IP) and cAMP formation
Cells were seeded into 24-well plates and grown to confluence. For determinations of cAMP formation, cells were labeled with [ 3 H]adenine (74 MBq/ml) in serum-free medium for 2-3 h. Thereafter, cells were washed twice in a phosphate-free HEPES-buffered salt solution that we call modified HBS or mHBS (130 mm NaCl, 5.4 mm KCl, 0.5 mm CaCl 2 , 0.9 mm MgSO 4 , 10 mm glucose, and 20 mm HEPES, pH 7.4). Phosphate was omitted to allow high concentrations of Ca 2ϩ to be used in the assays. The relatively low concentration of basal calcium was chosen to maintain the PCaR safely in an inactive state before increasing [Ca 2ϩ ] e or adding other metal ions. We have verified that both adenylyl cyclase as well as phosphoinositide turnover activity can be measured normally under these assay conditions. In some experiments with Gd 3ϩ (Figs. 2 and 3), MgCl 2 was substituted for MgSO 4 , as sulfate ions may form insoluble complexes with Gd 3ϩ . To assess inhibition of adenylyl cyclase by cations or other agents, cells were incubated at 37 C in mHBS containing 5 m forskolin, 1 mm isobutylmethylxanthine, and test compounds for 15 min. Thereafter, medium was aspirated, and cells were extracted by adding ice-cold 5% trichloroacetic acid. The extracts were analyzed for [ 3 H]cAMP using batch column chromatography (18) . For determinations of IP formation, cells were labeled with [ 3 H]inositol (74 MBq/ml) in serum-free medium for 24 h. After labeling, cells were washed once with mHBS and incubated with mHBS at 37 C in the presence of 20 mm LiCl to block inositol monophosphatase activity. Test compounds were then added, and incubations were continued for an additional 20 min. Thereafter, cells were extracted with 10 mm ice-cold formic acid, and IPs formed were determined after anion exchange chromatography as described previously (19) .
When PTX was used in experiments, cells were pretreated with the toxin (100 ng/ml) for at least 3 h during labeling with
Intracellular free calcium
Cells grown on round glass coverslips were loaded with the intracellular calcium indicator fluo-3 (5 m; 60 min, 37 C) in a buffer containing 120 mm NaCl, 22 mm NaHCO 3 , 6 mm KCl, 0.2 mm CaCl 2 , 1 mm MgCl 2 , 5 mm glucose, and 5 mm HEPES, pH 7.4. After loading, coverslips were mounted on an inverted Zeiss IM35 microscope (Zeiss, Zurich, Switzerland) in a thermostated perfusion chamber (37 C). Experiments were carried out using mHBS containing MgCl 2 instead of MgSO 4 as incubation buffer. The fluorescence excitation wavelength was set at 480 nm; emission was measured at 510 nm. Signals were recorded with a Deltaron HR 1700 MOS sensor camera (Fuji Photochemicals, Tokyo, Japan). Single cell calcium signals were calibrated as described by Kao et al. (20) using ionomycin and EGTA.
DNA synthesis
Cells were seeded into 96-well plates and grown to confluence. To synchronize cells in the G0/G1 phase of the cell cycle, cultures were serum deprived for 24 h. Thereafter, cells were incubated in serum-free medium containing [ 3 H]thymidine (74 MBq/ml), insulin (1 g/ml), and the indicated concentrations of cations or growth factors for an additional 24 h. The plates were then washed, and radioactivity incorporated into trichloroacetic acid-insoluble material was counted. When PTX was used in experiments, cells were pretreated with the toxin for at least 3 h during the serum deprivation phase. We have verified that the antibiotics present in our medium do not activate PCaR at the concentrations employed.
Results

CCL39 cells expressing rat PCaR show calcium-induced IP formation
Untransfected CCL39 fibroblasts did not show stimulation of phosphoinositide turnover, cell proliferation, or a modulation of adenylyl cyclase activity in response to variations in [Ca 2ϩ ] e between 1-10 mm (data not shown). After transfection of these cells with the rat PCaR cDNA, we isolated cell populations responding to increased [Ca 2ϩ ] e with a strong increase in IP formation. None of the cell populations showed a significant inhibition of adenylyl cyclase. Individual cell clones were isolated, and several clones expressing rat PCaR stably were characterized. The experiments described below were carried out using clone 39CaRc6, which showed strong responses to [Ca 2ϩ ] e in phosphoinositide turnover assays that were stable for more than 20 passages in culture. Figure 1 shows IP formation as a function of [Ca 2ϩ ] e and illustrates the effect of a first generation calcimimetic drug, NPS R-568 (17 and NPS R-568 was insensitive to pretreatment of cells with PTX (data not shown). We also found activation of the rat PCaR by strontium (EC 50 ϭ 8 mm), magnesium (EC 50 ϭ 15 mm), and polycations such as neomycin B (EC 50 ϭ 0.3 mm), but not with Al 3ϩ , which acts as a strong mitogen for osteoblasts (3, 4) . Unexpectedly, we were unable to detect receptor activation by the transition metal Gd 3ϩ in this type of assay. This is illustrated in Fig. 2 1-100 m. In contrast, the cation applied at 100 m almost fully suppressed the signal stimulated by increased [Ca 2ϩ ] e , which seemed to indicate antagonism. However, this effect was clearly not specific for Ca 2ϩ -induced signals. The same inhibition was observed when phosphoinositide turnover was stimulated with the AlF 4 Ϫ complex or with thrombin, a strong activator of this signaling pathway in CCL39 cells (11) . From these data we conclude that Gd 3ϩ cannot act as a full functional agonist on PCaR because of nonspecific inhibition of the phosphoinositide signaling system. No inhibitory effects on IP production were observed with Al 3ϩ applied between 1-100 m (data not shown).
We also compared the actions of Ca 2ϩ and Gd 3ϩ in measurements of intracellular free calcium using fluo-3 (Fig. 3) . Increased [Ca 2ϩ ] e as well as addition of NPS R-568 gave rise to strong intracellular calcium transients, whereas Gd 3ϩ stimulated signals of lower amplitude. This observation is in agreement with a lower apparent intrinsic activity of Gd 3ϩ compared with calcium.
Calcium and NPS R-568 stimulate DNA synthesis and cell proliferation
DNA synthesis reinitiation experiments were carried out in serum-free DMEM/F12 medium in the presence of 1 g/ml insulin. As the medium contained 0.8 mm phosphate, it was not possible to raise [Ca 2ϩ ] e above 5 mm without inducing calcium phosphate precipitates immediately. Under our assay conditions, calcium alone applied at a final concentration of 2-4 mm was found to stimulate DNA synthesis significantly (Fig. 4A ). However, a striking potentiation of this response was observed in the presence of 1 m NPS R-568. Thus, the mitogenic response measured with 2 mm Ca 2ϩ and 1 m NPS R-568 was comparable to the response to thrombin or 3% FCS. These data reflect the synergistic action of the cation and the calcimimetic at the level of phosphoinositide breakdown, as shown above. At a [Ca 2ϩ ] e of 1 mm, the calcimimetic also increased the serum effects, as expected for growth factors acting in conjunction. Neither calcium nor NPS R-568 exerted similar effects in untransfected CCL39 cells (data not shown).
There was no measurable stimulation of [ 3 H]thymidine incorporation with Gd 3ϩ applied at 1-100 m, and the same negative results were obtained with Al 3ϩ in this range of concentrations (data not shown). , and Gd 3ϩ (C). In A and C, the basal calcium concentration of the buffer was 0.2 mM; in B, 2 mM was used. Average changes (mean Ϯ SEM) in intracellular calcium derived from several identical experiments are given next to the corresponding representative traces.
As expected, PTX did not affect the mitogenic action of Ca 2ϩ , Ca 2ϩ plus NPS R-568, or FGF, whereas the responses to thrombin and FCS were clearly inhibited (Fig. 4B) .
To confirm and extend the DNA synthesis reinitiation data, we measured increases in cell numbers in cultures of 39CaRc6 cells maintained in serum-free medium supplemented with Ca 2ϩ and NPS R-568 as indicated in Fig. 5 . After 2 days in defined medium, significant cell proliferation was detected in cultures supplemented with Ca 2ϩ and the calcimimetic. However, saturating concentrations of NPS R-568 (1 m and higher) were not tolerated in long term cell culture, indicating toxicity. Optimal results were obtained with 0.3 m of the compound. It is probable that more selective and potent calcimimetics would give rise to still stronger increases in cell number.
Again, control experiments carried out with untransfected CCL39 cells did not reveal positive effects of Ca 2ϩ or NPS R-568 under our assay conditions (data not shown).
Discussion
The experiments reported here show that the rat PCaR expressed in fibroblasts is functional. It is coupled to the phosphoinositide signaling system and has the potential to trigger cell proliferation. Our experiments did not reveal a significant coupling of the receptor to PTX-sensitive G i proteins as experiments with bovine and human parathyroid cells had suggested (5, 14) . However, our results seem to confirm data reported in abstract form, showing that the rat PCaR is exclusively coupled to phosphoinositide turnover (21) .
In contrast to published data (5-8), we could not detect a significant activation of the rat PCaR by Gd 3ϩ when we measured IP formation. In fact, we found that this transition metal strongly inhibited IP formation stimulated by a variety of agonists in several cell systems at concentrations above 10 m (Fig. 2 and results not shown) Pearce et al. (22) working with 293 cells expressing the human PCaR. At first glance these rather negative results with Gd 3ϩ seem surprising, as Gd 3ϩ was the agonist used to isolate the bovine PCaR cDNA through expression cloning (6) . However, it is possible that the phosphoinositide signaling system in oocytes and various mammalian cells shows a different sensitivity to inhibition by Gd 3ϩ , thus leading to a different apparent pharmacology of the PCaR.
A second surprising result of the present study was the strong mitogenic response triggered by the rat PCaR in CCL39 cells. In this cell system, as in most other mesenchymal cells, receptors coupled exclusively to phosphoinositide turnover do not stimulate cell proliferation particularly well (10, 12, 13) . A probable explanation for our results supported by preliminary data could be a relatively high activity of phosphoinositide turnover activity maintained over time in the presence of NPS R-568, which may create a situation similar to that observed after expression in fibroblasts of a desensitization-defective mutant of the neurokinin NK-2 receptor (13) .
It is interesting to compare the mitogenic effects elicited by PCaR with those stimulated by the to date uncloned osteoblast calcium receptor, which may be a close relative of PCaR (4, 23 (3, 4) , we found that this cation does not interact with the rat PCaR. Furthermore, no stimulation of phosphoinositide turnover or intracellular calcium transients is detected in MC3T3-E1 cells stimulated by increased [Ca 2ϩ ] e or Gd 3ϩ (4) (Mailland, M., et al., manuscript in preparation). These data suggest that a different molecular entity is involved in mediating the mitogenic effects of cations in bone cells. This contention is further supported by the fact that we and others were unable to detect PCaR by PCR or Northern analysis in osteoblasts and that NPS R-568 does not modulate the mitogenic effects of cations on bone cells (Mailland, M., et al., manuscript in preparation).
